Eribulin mesylate 1 MG/2 ML VL 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCV0J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,606
Award facts
- Contract value 100% obligated
- $15,606.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $15,606.00 by the Defense Logistics Agency (DLA) on December 16, 2025, with an ultimate completion date of December 17, 2025. The contract covers the supply of Eribulin Mesylate 1 mg/2 ml vials in 2 ml quantities, a chemotherapy medication used in cancer treatment. This is a firm fixed price delivery order with no set-aside designation, awarded through competitive procurement. The award serves as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical vendor, providing brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards with DLA demonstrates its capability to meet federal procurement requirements across diverse medical product categories and transaction values. As the DLA plans to establish the next generation of Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards potentially involving several contractors, AmerisourceBergen remains positioned as a key supplier within the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DR26FCV0J?
SPE2DR26FCV0J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FCV0J worth?
The government has obligated $15,606 on SPE2DR26FCV0J.
Is contract SPE2DR26FCV0J an order under another contract?
Yes. SPE2DR26FCV0J is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCV0J competed?
The extent of competition for SPE2DR26FCV0J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award